Among these predicted miR-30b-5p and miR-30e-5p targets, KRAS, MYO5A and SLC4A7 were also validated to be altered in different HNSCC cell lines, in which KRAS was further validated as the target genes. The gene discussed is SLC4A7; the disease is head and neck squamous cell carcinoma.